Business Standard

Parenteral Drugs (India) reports consolidated net loss of Rs 14.54 crore in the September 2015 quarter

Image

Capital Market

Sales rise 18.17% to Rs 79.98 crore

Net Loss of Parenteral Drugs (India) reported to Rs 14.54 crore in the quarter ended September 2015 as against net loss of Rs 20.59 crore during the previous quarter ended September 2014. Sales rose 18.17% to Rs 79.98 crore in the quarter ended September 2015 as against Rs 67.68 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales79.9867.68 18 OPM %7.704.79 -PBDT-7.26-13.92 48 PBT-14.02-19.67 29 NP-14.54-20.59 29

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 10 2015 | 9:16 AM IST

Explore News